查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物製造中病毒检测和定量的全球市场（2023-2032）：按产品类型、技术、用途、最终用户和地区进行分析和预测
市场调查报告书
商品编码
1316427

生物製造中病毒检测和定量的全球市场（2023-2032）：按产品类型、技术、用途、最终用户和地区进行分析和预测

Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus on Offering Type, Technology, Application, End User, and Region - Analysis and Forecast, 2023-2032
出版日期: | 出版商: BIS Research | 英文 273 Pages | 商品交期: 1-5个工作天内

价格

行业概况

全球生物製造中的病毒检测和定量市场规模将从 2022 年的 4.743 亿美元增至 2032 年的 11.497 亿美元，预测期内年复合成长率为 9.37%

生物製药利用率的提高和病毒检测行业的技术进步预计将推动市场的增长。

主要市场统计数据
开始年份 2023年
预测年份 2032
第一年市场规模 5.134 亿美元（2023 年）
市场规模预测 11.497 亿美元（2032 年）
年复合成长率（%）： 9.37%

市场生命週期阶段

全球生物製造中的病毒检测和定量市场正处于持续发展阶段。由于生物製药的日益普及，市场正在蓬勃发展。稳健的质量控制流程对于确保生物製药的安全性、有效性和一致性至关重要。因此，生物製药製造过程中对量化病毒污染物的消耗品和仪器的需求不断增加预测将推动市场增长。

从产品类型来看，消耗品细分市场将在 2022 年占据较大份额。试剂盒、检测方法和配件的采用增加促进了该领域的增长。消耗品是在整个病毒检测过程中不断消耗的产品或材料，有几种消耗品是在生物製造过程中用于病毒检测和定量以简化病毒样本的检测和分析所使用的。

从技术来看，PCR 技术领域将占据较大份额，并在 2022 年引领市场。聚合酶炼式反应（PCR）是分子生物学和病毒检测领域常用的技术。此外，从用途来看，血液及血液製品製造业占有较大份额，并将在2022年引领市场。病毒检测是确保生物製造过程中血液和血液製品安全和质量的重要组成部分。该测试识别并测量血液样本中存在的病毒颗粒和病毒核酸。采用核酸扩增测试（NAT）等方法来识别和测量病毒核酸。

从最终用户来看，生命科学公司将在 2022 年占据最大份额。生命科学中的病毒检测和定量是指在药物开发、製造和评估过程中对病毒颗粒或病毒成分的测量和评估。病毒载量的检测和定量，即每个样品或系统中存在的病毒的量或浓度，是该领域的基本要求。

按地区划分，由于主要参与者的存在和资金的增加，北美市场将在 2022 年占据最大份额，达到 38.72%。另一方面，由于持续的研发和支持性的监管环境，预计亚太地区在预测期内将以 10.47% 的年复合成长率实现最大增长。

本报告研究了生物製造中的病毒检测和定量市场，提供了市场概况、法律和监管框架、各种业务影响因素和商机的分析、市场规模趋势和预测、各个细分市场和地区。我们整理了另一份报告深入分析、竞争格局、主要参与者简介等。

目录

第1章产品定义

第2章市场范围

第3章调查方法

第4章市场概况

  • 概述
  • 当前市场规模及未来增长潜力

第5章行业展望

  • 监管状况
    • 美国法律要求和框架
    • 欧洲法律要求和框架
    • 亚太地区的法律要求和框架

第6章全球生物製造病毒检测和定量市场：市场动态

  • 商务促进因素
  • 业务限制
  • 商业机会

第7章全球生物製造市场中的病毒检测和定量（按产品类型）

  • 概述
  • 消耗品
    • 试剂盒检测
    • 配件
  • 设备
  • 服务

第8章全球生物製造病毒检测和定量市场（按技术）

  • 概述
  • PCR
  • 流式细胞术
  • ELISA
  • 噬菌斑测定
  • 其他的

第9章全球生物製造病毒检测和定量市场（按用途）

  • 概述
  • 血液和血液製品的製造
  • 细胞和基因治疗产品的製造
  • 干细胞产品的製造
  • 纸巾及纸巾产品的製造
  • 疫苗和治疗药物的製造

第10章全球生物製造病毒检测和定量市场（按最终用户）

  • 概述
  • 生命科学公司
  • 测试实验室
  • CRO/CDMO

第11章全球生物製造市场中的病毒检测和定量（按地区）

  • 概述
  • 北美
  • 欧洲
  • 亚太地区
  • 拉美
  • 中东/非洲

第12章市场：竞争基准和公司概况

  • 概述
  • 公司股份分析
  • 生物製造中病毒检测和定量生态系统中的公司
  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Charles River Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Genscript Biotech Corporation
  • Norgen Biotek Corp.
Product Code: BHL1392SA

“Global Biomanufacturing Viral Detection and Quantification Market to Reach $1,149.7 Million by 2032.”

Industry Overview

The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032. The global biomanufacturing viral detection and quantification market is expected to be driven by the rising utilization of biopharmaceutical products and the technological advancements in the viral testing industry.

KEY MARKET STATISTICS
Start Year2023
Forecast Year2032
Start Value$513.4 Million in 2023
Forecast Value$1,149.7 Million by 2032
CAGR %9.37%

Market Lifecycle Stage

The global biomanufacturing viral detection and quantification market is in progressing phase. The biomanufacturing viral detection and quantification market is experiencing rapid growth due to the increasing adoption of biopharmaceuticals. Robust quality control processes are essential to ensure the safety, efficacy, and consistency of biopharmaceuticals. These factors are expected to drive the demand for consumables and instruments for quantification of viral contaminants during biomanufacturing of biologics, thereby augmenting the growth of the biomanufacturing viral detection and quantification market.

Impact

Viral detection and quantification is used to evaluate and improve the biomanufacturing process throughout process development. Manufacturers can detect potential viral contamination sources and make the required adjustments to reduce risks and boost process effectiveness by detecting and quantifying viral contaminants at different stages. Emerging cell and gene therapies, along with other biotherapeutics, are at risk of contamination, including viral contaminants. Detecting these contaminants early on is important to prevent any delays in the production process, which can have a direct impact on the commercialization of therapy. Cell and gene therapies utilize viral vectors to deliver therapeutic genes or manipulate cells for therapeutic purposes. In addition, the entry of several established players, such as Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories, Bio-Rad Laboratories, Inc., QIAGEN N.V., and others, is expected to aid the market growth.

Due to better cleanliness, people witnessed global advancement in the control of infectious contamination over the past few years. The market for biomanufacturing viral detection and quantification is expanding due to the growing demand for precise viral testing in the biomanufacturing of therapies. In conclusion, as the field of emerging cell and gene therapies continues to advance, it is imperative to address the potential risks of viral contamination.

Market Segmentation:

Segmentation 1: by Offering Type

  • Consumables
  • Instruments
  • Services

Consumables Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type)

Based on offering type, the consumables segment dominated the global biomanufacturing viral detection and quantification market in FY2022. The increasing adoption of kits, assays, and accessories contributed to the prominence of the consumables segment. Consumables are products and materials that are constantly consumed throughout the viral testing process. Several consumables are utilized in viral detection and quantification during biomanufacturing to simplify testing and analysis of viral samples. These consumables are necessary to carry out the several procedures and tests required to determine the quantity or concentration of a particular virus in a biological sample.

Segmentation 2: by Technology

  • PCR
  • ELISA
  • Flow Cytometry
  • Plaque Assay
  • Others

PCR Technology Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Technology)

Based on technology, the PCR segment dominated the global biomanufacturing viral detection and quantification market in FY2022. In the field of molecular biology and viral testing, polymerase chain reaction (PCR) is a commonly used technique. It is a method for identifying and measuring viral nucleic acids that are sensitive and focused during the production of biopharmaceuticals. In addition, PCR is essential for measuring the viral load, or the quantity of viral genetic material, in a biological sample.

Segmentation 3: by Application

  • Blood and Blood Products Manufacturing
  • Vaccines and Therapeutics Manufacturing
  • Cellular and Gene Therapy Products Manufacturing
  • Stem Cell Products Manufacturing
  • Tissue and Tissue Products Manufacturing

Blood and Blood Products Manufacturing Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Application)

Based on application, the global biomanufacturing viral detection and quantification market was dominated by the blood and blood products manufacturing segment in FY2022. In biomanufacturing processes, viral testing is an essential component in verifying the safety and quality of blood and blood products. This test involves identifying and measuring viral particles or viral nucleic acids that are present in blood samples. To identify and measure viral nucleic acids, methods such as nucleic acid amplification testing (NAT) are often employed.

Segmentation 4: by End User

  • Life Science Companies
  • Testing Laboratories
  • CROs and CDMOs

Life Science Companies to Continue its Dominance in the End User Segment

Based on end user, the life science companies segment accounted for the largest share of the global biomanufacturing viral detection and qauntification market in FY2022. In the life science sector, viral detection and quantification refers to the measuring and evaluation of viral particles or viral components at distinct stages of medication development, production, and evaluation. Viral load, or the quantity or concentration of viruses present in each sample or system, must be detected and quantified.

Segmentation 5: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

North America held the largest share of 38.72% in 2022 in the global biomanufacturing viral detection and quantification market, owing to the presence of most key players and rising funding in the region.

In addition, Asia-Pacific is expected to grow at the highest CAGR of 10.47% in the forecast period 2023-2032, owing to the continuous research and development in the viral detection and quantification industry as well as the supportive regulatory landscape.

Demand - Drivers and Limitations

Market Demand Drivers:

  • Increasing Utilization of Biopharmaceuticals
  • Technological Advancements in Viral Detection and Quantification

Market Restraints:

  • High Cost of Advanced Viral Detection and Quantification Equipment
  • Lack of Trained Professionals in the Field of Viral Detection and Quantification

Market Opportunities:

  • Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

How can this report add value to an organization?

  • Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.
  • Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.
  • Competitive Strategy: Key players in the global biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the global biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

Viral contamination poses a significant risk to both animal- and human-derived biopharmaceuticals. This form of contamination can occur at any stage of the bioproduction process, necessitating viral testing studies and the implementation of viral clearance methods by biomanufacturers. In this study, several types of fundamental technologies have been examined that have facilitated these advances, namely, polymerase chain reaction (PCR), plaque assays, flow cytometry, and enzyme-linked immunosorbent assay (ELISA), among others. The global biomanufacturing viral detection and quantification market is strongly driven by the continuous introduction of new technologies as well as increased investments and funding from both the government and private sectors.

Key Companies Profiled:

  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Charles River Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Genscript Biotech Corporation
  • Norgen Biotek Corp.

Table of Contents

1 Product Definition

  • 1.1 Inclusion and Exclusion Criteria

2 Market Scope

  • 2.1 Scope of the Study
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

4 Market Overview

  • 4.1 Overview
  • 4.2 Current Market Size and Future Growth Potential, $Billion, 2022-2032

5 Industry Outlook

  • 5.1 Regulatory Landscape
    • 5.1.1 Legal Requirements and Frameworks in the U.S.
      • 5.1.1.1 Marketing Authorization
    • 5.1.2 Legal Requirements and Frameworks in Europe
    • 5.1.3 Legal Requirements and Frameworks in Asia-Pacific
      • 5.1.3.1 Legal Requirements and Framework in Japan

6 Global Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

  • 6.1 Business Drivers
    • 6.1.1 Increasing Utilization of Biopharmaceuticals
    • 6.1.2 Technological Advancements in Viral Detection and Quantification
    • 6.1.3 Impact Analysis
  • 6.2 Business Restraints
    • 6.2.1 High Cost of Advanced Viral Detection and Quantification Equipment
    • 6.2.2 Lack of Trained Professionals in the Field of Viral Detection and Quantification
    • 6.2.3 Impact Analysis
  • 6.3 Business Opportunities
    • 6.3.1 Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

7 Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type), Value ($Million), 2022-2032

  • 7.1 Overview
  • 7.2 Consumables
    • 7.2.1 Kits and Assays
    • 7.2.2 Accessories
  • 7.3 Instruments
  • 7.4 Services

8 Global Biomanufacturing Viral Detection and Quantification Market (by Technology), Value ($Million), 2022-2032

  • 8.1 Overview
  • 8.2 PCR
  • 8.3 Flow Cytometry
  • 8.4 ELISA
  • 8.5 Plaque Assay
  • 8.6 Others

9 Global Biomanufacturing Viral Detection and Quantification Market (by Application), Value ($Million), 2022-2032

  • 9.1 Overview
  • 9.2 Blood and Blood Products Manufacturing
  • 9.3 Cellular and Gene Therapy Products Manufacturing
  • 9.4 Stem Cell Products Manufacturing
  • 9.5 Tissue and Tissue Products Manufacturing
  • 9.6 Vaccines and Therapeutics Manufacturing

10 Global Biomanufacturing Viral Detection and Quantification Market (by End User), Value ($Million), 2022-2032

  • 10.1 Overview
  • 10.2 Life Science Companies
  • 10.3 Testing Laboratories
  • 10.4 CROs and CDMOs

11 Global Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    • 11.2.2 North America Biomanufacturing Viral Detection and Quantification Market (by Technology)
    • 11.2.3 North America Biomanufacturing Viral Detection and Quantification Market (by Application)
    • 11.2.4 North America Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 11.2.5 North America Biomanufacturing Viral Detection and Quantification Market (by Country)
      • 11.2.5.1 U.S.
        • 11.2.5.1.1 U.S. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.2.5.1.2 U.S. Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.2.5.1.3 U.S. Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.2.5.1.4 U.S. Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.2.5.2 Canada
        • 11.2.5.2.1 Canada Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.2.5.2.2 Canada Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.2.5.2.3 Canada Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.2.5.2.4 Canada Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 11.3 Europe
    • 11.3.1 Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    • 11.3.2 Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
    • 11.3.3 Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
    • 11.3.4 Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 11.3.5 Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
      • 11.3.5.1 Germany
        • 11.3.5.1.1 Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.3.5.1.2 Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.3.5.1.3 Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.3.5.1.4 Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.3.5.2 U.K.
        • 11.3.5.2.1 U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.3.5.2.2 U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.3.5.2.3 U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.3.5.2.4 U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.3.5.3 France
        • 11.3.5.3.1 France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.3.5.3.2 France Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.3.5.3.3 France Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.3.5.3.4 France Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.3.5.4 Spain
        • 11.3.5.4.1 Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.3.5.4.2 Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.3.5.4.3 Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.3.5.4.4 Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.3.5.5 Italy
        • 11.3.5.5.1 Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.3.5.5.2 Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.3.5.5.3 Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.3.5.5.4 Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.3.5.6 Rest-of-Europe
        • 11.3.5.6.1 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.3.5.6.2 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.3.5.6.3 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.3.5.6.4 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 11.4 Asia-Pacific
    • 11.4.1 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    • 11.4.2 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
    • 11.4.3 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
    • 11.4.4 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 11.4.5 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
      • 11.4.5.1 China
        • 11.4.5.1.1 China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.4.5.1.2 China Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.4.5.1.3 China Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.4.5.1.4 China Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.4.5.2 Japan
        • 11.4.5.2.1 Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.4.5.2.2 Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.4.5.2.3 Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.4.5.2.4 Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.4.5.3 India
        • 11.4.5.3.1 India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.4.5.3.2 India Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.4.5.3.3 India Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.4.5.3.4 India Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.4.5.4 Australia
        • 11.4.5.4.1 Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.4.5.4.2 Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.4.5.4.3 Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.4.5.4.4 Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.4.5.5 South Korea
        • 11.4.5.5.1 South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.4.5.5.2 South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.4.5.5.3 South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.4.5.5.4 South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.4.5.6 Rest-of-Asia-Pacific
        • 11.4.5.6.1 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.4.5.6.2 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.4.5.6.3 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.4.5.6.4 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 11.5 Latin America
    • 11.5.1 Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    • 11.5.2 Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology)
    • 11.5.3 Latin America Biomanufacturing Viral Detection and Quantification Market (by Application)
    • 11.5.4 Latin America Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.5.4.1 Brazil
        • 11.5.4.1.1 Brazil Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.5.4.1.2 Brazil Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.5.4.1.3 Brazil Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.5.4.1.4 Brazil Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.5.4.2 Mexico
        • 11.5.4.2.1 Mexico Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.5.4.2.2 Mexico Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.5.4.2.3 Mexico Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.5.4.2.4 Mexico Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.5.4.3 Rest-of-Latin America
        • 11.5.4.3.1 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.5.4.3.2 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.5.4.3.3 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.5.4.3.4 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 11.6 Middle East and Africa
    • 11.6.1 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    • 11.6.2 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
    • 11.6.3 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
    • 11.6.4 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.6.4.1 South Africa
        • 11.6.4.1.1 South Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.6.4.1.2 South Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.6.4.1.3 South Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.6.4.1.4 South Africa Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.6.4.2 Israel
        • 11.6.4.2.1 Israel Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.6.4.2.2 Israel Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.6.4.2.3 Israel Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.6.4.2.4 Israel Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.6.4.3 U.A.E.
        • 11.6.4.3.1 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.6.4.3.2 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.6.4.3.3 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.6.4.3.4 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.6.4.4 Saudi Arabia
        • 11.6.4.4.1 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.6.4.4.2 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.6.4.4.3 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.6.4.4.4 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 11.6.4.5 Rest-of-Middle East and Africa
        • 11.6.4.5.1 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 11.6.4.5.2 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 11.6.4.5.3 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 11.6.4.5.4 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User)

12 Markets - Competitive Benchmarking & Company Profiles

  • 12.1 Overview
  • 12.2 Company Share Analysis
  • 12.3 Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
  • 12.4 Danaher Corporation
    • 12.4.1 Company Overview
    • 12.4.2 Role of Danaher Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.4.3 Key Competitors
    • 12.4.4 Financials
    • 12.4.5 Key Insights about the Financial Health of the Company
    • 12.4.6 Analyst Perspective
  • 12.5 Merck KGaA
    • 12.5.1 Company Overview
    • 12.5.2 Role of Merck KGaA in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.5.3 Key Competitors
    • 12.5.4 Financials
    • 12.5.5 Key Insights about the Financial Health of the Company
    • 12.5.6 Analyst Perspective
  • 12.6 New England Biolabs
    • 12.6.1 Company Overview
    • 12.6.2 Role of New England Biolabs in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.6.3 Key Competitors
    • 12.6.4 Analyst Perspective
  • 12.7 TAKARA HOLDINGS INC.
    • 12.7.1 Company Overview
    • 12.7.2 Role of TAKARA HOLDINGS INC. in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.7.3 Key Competitors
    • 12.7.4 Financials
    • 12.7.5 Key Insights about the Financial Health of the Company
    • 12.7.6 Analyst Perspective
  • 12.8 Thermo Fisher Scientific Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Role of Thermo Fisher Scientific Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.8.3 Key Competitors
    • 12.8.4 Financials
    • 12.8.5 Key Insights about the Financial Health of the Company
    • 12.8.6 Analyst Perspective
  • 12.9 Agilent Technologies, Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Role of Agilent Technologies, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.9.3 Key Competitors
    • 12.9.4 Financials
    • 12.9.5 Key Insights about the Financial Health of the Company
    • 12.9.6 Analyst Perspective
  • 12.1 Sartorius AG
    • 12.10.1 Company Overview
    • 12.10.2 Role of Sartorius AG in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.10.3 Key Competitors
    • 12.10.4 Financials
    • 12.10.5 Analyst Perspective
  • 12.11 Charles River Laboratories
    • 12.11.1 Company Overview
    • 12.11.2 Role of Charles River Laboratories in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.11.3 Key Competitors
    • 12.11.4 Financials
    • 12.11.5 Analyst Perspective
  • 12.12 Bio-Rad Laboratories, Inc.
    • 12.12.1 Company Overview
    • 12.12.2 Role of Bio-Rad Laboratories, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.12.3 Key Competitors
    • 12.12.4 Financials
    • 12.12.5 Key Insights about the Financial Health of the Company
    • 12.12.6 Analyst Perspective
  • 12.13 PerkinElmer, Inc.
    • 12.13.1 Company Overview
    • 12.13.2 Role of PerkinElmer, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.13.1 Key Competitors
    • 12.13.2 Financials
    • 12.13.3 Key Insights about the Financial Health of the Company
    • 12.13.4 Analyst Perspective
  • 12.14 Promega Corporation
    • 12.14.1 Company Overview
    • 12.14.2 Role of Promega Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.14.3 Key Competitors
    • 12.14.4 Analyst Perspective
  • 12.15 QIAGEN N.V.
    • 12.15.1 Company Overview
    • 12.15.2 Role of QIAGEN N.V. in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.15.3 Key Competitors
    • 12.15.4 Financials
    • 12.15.5 Key Insights about the Financial Health of the Company
    • 12.15.6 Analyst Perspective
  • 12.16 Genscript Biotech Corporation
    • 12.16.1 Company Overview
    • 12.16.2 Role of Genscript Biotech Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.16.3 Key Competitors
    • 12.16.4 Financials
    • 12.16.5 Key Insights about the Financial Health of the Company
    • 12.16.6 Analyst Perspective
  • 12.17 Norgen Biotek Corp.
    • 12.17.1 Company Overview
    • 12.17.2 Role of Norgen Biotek Corp. in the Global Biomanufacturing Viral Detection and Quantification Market
    • 12.17.3 Key Competitors
    • 12.17.4 Analyst Perspective

List of Figures

  • Figure 1: Global Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 2: Global Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
  • Figure 3: Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
  • Figure 4: Global Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
  • Figure 5: Global Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
  • Figure 6: Global Biomanufacturing Viral Detection and Quantification Market (by Region), $Billion, 2022 and 2032
  • Figure 7: Global Biomanufacturing Viral Detection and Quantification Market Segmentation
  • Figure 8: Global Biomanufacturing Viral Detection and Quantification Market: Research Methodology
  • Figure 9: Primary Research Methodology
  • Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 11: Top-Down Approach (Segment-Wise Analysis)
  • Figure 12: Global Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 13: Steps Involved in FDA Regulation
  • Figure 14: Steps for Obtaining Marketing Authorization
  • Figure 15: Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
  • Figure 16: Global Biomanufacturing Viral Detection and Quantification Market (Consumables), $Billion, 2022-2032
  • Figure 17: Global Biomanufacturing Viral Detection and Quantification Market (Kits and Assays), $Billion, 2022-2032
  • Figure 18: Global Biomanufacturing Viral Detection and Quantification Market (Accessories), $Billion, 2022-2032
  • Figure 19: Global Biomanufacturing Viral Detection and Quantification Market (Instruments), $Billion, 2022-2032
  • Figure 20: Global Biomanufacturing Viral Detection and Quantification Market (Services), $Billion, 2022-2032
  • Figure 21: Global Biomanufacturing Viral Detection and Quantification Market (by Technology)
  • Figure 22: Steps Involved in PCR for Viral Detection and Quantification
  • Figure 23: Global Biomanufacturing Viral Detection and Quantification Market (PCR), $Billion, 2022-2032
  • Figure 24: Steps Involved in Flow Cytometry for Viral Detection and Quantification
  • Figure 25: Global Biomanufacturing Viral Detection and Quantification Market (Flow Cytometry), $Billion, 2022-2032
  • Figure 26: Steps Involved in ELISA for Viral Detection and Quantification
  • Figure 27: Global Biomanufacturing Viral Detection and Quantification Market (ELISA), $Billion, 2022-2032
  • Figure 28: Global Biomanufacturing Viral Detection and Quantification Market (Plaque Assay), $Billion, 2022-2032
  • Figure 29: Global Biomanufacturing Viral Detection and Quantification Market (Others), $Billion, 2022-2032
  • Figure 30: Global Biomanufacturing Viral Detection and Quantification Market (by Application)
  • Figure 31: Global Biomanufacturing Viral Detection and Quantification Market (Blood and Blood Products Manufacturing), $Billion, 2022-2032
  • Figure 32: Global Biomanufacturing Viral Detection and Quantification Market (Cellular and Gene Therapy Products Manufacturing), $Billion, 2022-2032
  • Figure 33: Global Biomanufacturing Viral Detection and Quantification Market (Stem Cell Products Manufacturing), $Billion, 2022-2032
  • Figure 34: Global Biomanufacturing Viral Detection and Quantification Market (Tissue and Tissue Products Manufacturing), $Billion, 2022-2032
  • Figure 35: Global Biomanufacturing Viral Detection and Quantification Market (Vaccines and Therapeutics Manufacturing), $Billion, 2022-2032
  • Figure 36: Global Biomanufacturing Viral Detection and Quantification Market (by End User)
  • Figure 37: Global Biomanufacturing Viral Detection and Quantification Market (Life Science Companies), $Billion, 2022-2032
  • Figure 38: Use of Viral Detection and Quantification in Testing Laboratories
  • Figure 39: Global Biomanufacturing Viral Detection and Quantification Market (Testing Laboratories) $Billion, 2022-2032
  • Figure 40: Global Biomanufacturing Viral Detection and Quantification Market (CROs and CDMOs) $Billion, 2022-2032
  • Figure 41: Global Biomanufacturing Viral Detection and Quantification Market (by Region)
  • Figure 42: North America: Market Dynamics
  • Figure 43: North America Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 44: North America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 45: North America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 46: North America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 47: North America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 48: U.S. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 49: U.S. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 50: U.S. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 51: U.S. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 52: U.S. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 53: Canada Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 54: Canada Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 55: Canada Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 56: Canada Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 57: Canada Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 58: Europe: Market Dynamics
  • Figure 59: Europe Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 60: Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 61: Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 62: Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 63: Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 64: Germany Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 65: Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 66: Germany Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 67: Germany Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 68: Germany Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 69: U.K. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 70: U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 71: U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 72: U.K. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 73: U.K. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 74: France Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 75: France Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 76: France Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 77: France Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 78: France Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 79: Spain Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 80: Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 81: Spain Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 82: Spain Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 83: Spain Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 84: Italy Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 85: Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 86: Italy Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 87: Italy Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 88: Italy Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 89: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 90: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 91: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 92: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 93: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 94: Measures Undertaken by APAC to Enhance its Viral Testing Capacity
  • Figure 95: Asia-Pacific: Market Dynamics
  • Figure 96: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 97: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 98: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 99: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 100: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 101: China Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 102: China Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 103: China Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 104: China Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 105: China Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 106: Japan Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 107: Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 108: Japan Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 109: Japan Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 110: Japan Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 111: India Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 112: India Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 113: India Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 114: India Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 115: India Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 116: Australia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 117: Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 118: Australia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 119: Australia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 120: Australia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 121: South Korea Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 122: South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 123: South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 124: South Korea Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 125: South Korea Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 126: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 127: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 128: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 129: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 130: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 131: Latin America: Market Dynamics
  • Figure 132: Latin America Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 133: Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 134: Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 135: Latin America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 136: Latin America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 137: Brazil Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 138: Brazil Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 139: Brazil Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 140: Brazil Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 141: Brazil Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 142: Mexico Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 143: Mexico Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 144: Mexico Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 145: Mexico Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 146: Mexico Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 147: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 148: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 149: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 150: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 151: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 152: Middle East and Africa: Market Dynamics
  • Figure 153: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 154: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 155: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 156: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 157: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 158: South Africa Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 159: South Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 160: South Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 161: South Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 162: South Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 163: Israel Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 164: Israel Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 165: Israel Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 166: Israel Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 167: Israel Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 168: U.A.E. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 169: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 170: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 171: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 172: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 173: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 174: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 175: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 176: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 177: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 178: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 179: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 180: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 181: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 182: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 183: Global Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
  • Figure 184: Global Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
  • Figure 185: Danaher Corporation: Product Portfolio
  • Figure 186: Danaher Corporation: Overall Financials, $Million, 2020-2022
  • Figure 187: Danaher Corporation: Revenue (by Segment), $Million, 2020-2022
  • Figure 188: Danaher Corporation: Revenue (by Region), $Million, 2020-2022
  • Figure 189: Danaher Corporation: R&D Expenditure, $Million, 2020-2022
  • Figure 190: Merck KGaA: Product Portfolio
  • Figure 191: Merck KGaA: Overall Financials, $Million, 2020-2022
  • Figure 192: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
  • Figure 193: Merck KGaA: Revenue (by Region), $Million, 2020-2022
  • Figure 194: Merck KGaA: R&D Expenditure, $Million, 2020-2022
  • Figure 195: New England Biolabs: Product Portfolio
  • Figure 196: TAKARA HOLDINGS INC.: Product Portfolio
  • Figure 197: TAKARA HOLDINGS INC.: Overall Financials, $Million, 2020-2022
  • Figure 198: TAKARA HOLDINGS INC.: Revenue (by Region), $Million, 2020-2022
  • Figure 199: TAKARA HOLDINGS INC.: R&D Expenditure, $Million, 2020-2022
  • Figure 200: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 201: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
  • Figure 202: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
  • Figure 203: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
  • Figure 204: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 205: Agilent Technologies, Inc.: Product Portfolio
  • Figure 206: Agilent Technologies, Inc.: Overall Financials, $Million, 2020-2022
  • Figure 207: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2020-2022
  • Figure 208: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2020-2022
  • Figure 209: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 210: Sartorius AG: Product Portfolio
  • Figure 211: Sartorius AG: Overall Financials, $Million, 2020-2022
  • Figure 212: Sartorius AG: Revenue (by Segment), $Million, 2020-2022
  • Figure 213: Sartorius AG: Revenue (by Region), $Million, 2020-2022
  • Figure 214: Charles River Laboratories: Product Portfolio
  • Figure 215: Charles River Laboratories: Overall Financials, $Million, 2020-2022
  • Figure 216: Charles River Laboratories: Revenue (by Segment), $Million, 2020-2022
  • Figure 217: Charles River Laboratories: Revenue (by Region), $Million, 2020-2022
  • Figure 218: Bio-Rad Laboratories, Inc.: Product Portfolio
  • Figure 219: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2020-2022
  • Figure 220: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2020-2022
  • Figure 221: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2020-2022
  • Figure 222: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 223: PerkinElmer, Inc.: Product Portfolio
  • Figure 224: PerkinElmer, Inc.: Overall Financials, $Million, 2021-2023
  • Figure 225: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2021-2023
  • Figure 226: PerkinElmer, Inc.: Revenue (by Region), $Million, 2021-2023
  • Figure 227: PerkinElmer, Inc.: R&D Expenditure, $Million, 2021-2023
  • Figure 228: Promega Corporation: Product Portfolio
  • Figure 229: QIAGEN N.V.: Product Portfolio
  • Figure 230: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
  • Figure 231: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
  • Figure 232: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
  • Figure 233: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
  • Figure 234: Genscript Biotech Corporation: Product Portfolio
  • Figure 235: Genscript Biotech Corporation: Overall Financials, $Million, 2020-2022
  • Figure 236: Genscript Biotech Corporation: Revenue (by Segment), $Million, 2020-2022
  • Figure 237: Genscript Biotech Corporation: Revenue (by Region), $Million, 2020-2022
  • Figure 238: Genscript Biotech Corporation: R&D Expenditure, $Million, 2020-2022
  • Figure 239: Norgen Biotek Corp.: Product Portfolio

List of Tables

  • Table 1: Global Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
  • Table 2: Key Questions Answered in the Report
  • Table 3: Methods of Virus Detection and Quantification
  • Table 4: Biomanufacturing Viral Detection and Quantification Market: Global Regulatory Scenario
  • Table 5: Technological Advancement in the Field of Viral Testing
  • Table 6: Impact Analysis: Business Drivers
  • Table 7: Impact Analysis: Business Restraints